+7 (499) 340 10 14

7 Nosologies: Tracking

A draft of resolution of the Government “On approval of the principles of monitoring of movement and account of drugs intended for patients with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, patients after organ and(or) tissue transplantation in subjects of the Russian Federation”.

According to the document in an established order Russian Ministry of Health performs monitoring of movement and accounting of drugs in regions of the Russian Federation. Specifically the following forms have been developed by the ministry:

No 1 “Information on the list and quantities of drugs intended for persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, patients after organ and(or) tissue transplantation”,

No 2 “Information on deficiency of drugs, intended for persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, patients after organ and(or) tissue transplantation”,

No 3 “Information on excess of drugs, intended for persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, patients after organ and(or) tissue transplantation”, requiring approval by the order of the Ministry of Healthcare of the Russian Federation.

Document approval will continue till September 8, 2016.

^
LABMGMU LABMGMU +7 (499) 340 10 14 info@labmgmu.ru 119435, Moscow, Malaya Pirogovskay str. 13-1, floor 4